Icon Plc ICLR shares are crashing in Thursday’s premarket session as the company disclosed an update on its upcoming earnings report. The clinical research organisation disclosed an ongoing internal ...

ICON plc, (NASDAQ: ICLR) today announced that it intends to release its fourth quarter and full year 2025 earnings results on or prior to April 30, 2026. The Company also announced an ongoing internal ...

Investing.com -- ICON plc (NASDAQ:ICLR) shares fell 30% Thursday after the company announced an internal investigation into its accounting practices and withdrew its 2025 financial guidance.

ICON Plc shares plunged after the health care services contractor said it may have overstated some of its past revenue and ...

Investing.com -- ICON plc (NASDAQ:ICLR) stock plummeted 32% on Thursday after the clinical research organization announced an internal accounting investigation and delayed its fourth quarter and full ...

The number of staff at Icon PLC, a Dublin-headquartered clinical researcher for pharmaceutical firms, has fallen by 1,800 people worldwide amid “strong cost control” at the US-listed group. Last week, ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ICON plc (NASDAQ: ICLR) resulting from allegations that ...

Orbis Investment Management released its Q4 2025 investor letter for “Orbis SICAV International Equity Fund”. The Strategy reported a positive year in 2025, with returns driven more by stock-specific ...

ICON plc is a world-leading clinical research organisation powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, ...

ICON plc (NASDAQ: ICLR) today announced a significant expansion of oncology research capabilities within its Accellacare Site Network through the opening of the Brian Moran Cancer Institute at Duly ...